Skip to main content

Table 3 Multivariate analysis of clinical and molecular prognosticators in adult medulloblastomas

From: Clinical and mutational profiles of adult medulloblastoma groups

  HR (95% CI) p value
Age 0.869 (0.755–1.002) 0.053
Sex (male versus female) 27.878 (0.382–2035.342) 0.128
Molecular group   0.407
 SHH versus WNT 0.894 (0.022–36.018) 0.953
 Group 3 versus WNT 5.903 (0.225–155.063) 0.287
 Group 4 versus WNT 0.306 (0.006–14.994) 0.551
Histological type   0.026
 Desmoplastic/nodular versus classic 0.467 (0.046–4.746) 0.520
 LCA versus classic 129.534 (2.871–5844.831) 0.012
Metastasis 7.78 (1.207–50.147) 0.031
Adjuvant therapy 0.283 (0.007–11.612) 0.506
KMT2C mutation 6.468 (1.035–40.404) 0.046
  1. Bold values are p<0.05 and q<0.05